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ABSTRACT                                                                                                                                                                                                                   
The Orthopoxvirus (OPV) and the Molluscum contagiosum virus (MCV) are Poxviruses involved in viruses skin lesions in 
humans. OPV infects many vertebrates and MCV mainly infects humans. A diagnostic confusion is often observed between  
the clinical lesions due to the different Poxviruses firstly and secondly  with other viruses like the virus of the chickenpox. 
In Côte d'Ivoire, the diagnosis of MCV remains essentially clinical and that of OPV is non-existent despite the risk of 
circulation of the virus. This study aims to implementthe molecular detection of the OPV and the MVC in Côte d'Ivoire. 
Material and method: Cowpoxvirus DNA and 21 DNA extracts from suspicious cutaneous lesions of the MCV were 
analyzed by conventional PCR. The consensus primers (EACP1, EACP2) designed from the surface hemagglutin gene were 
used for the detection of the OPVs and the primers (MCV1, MCV2) targeting the K fragment of the MCV were used for the 
MCV’s detection  . A growing dilution series of the Cowpoxvirus DNA and the MCV allowed the study of the method’s 
sensitivity used. The DNAs of S.aureus, M. ulcerans, VZV, HSV, the Measles virus and Varicella virus were used for the 
specificity tests. Results: The detection of the OPV from the Cowpoxvirus viral strain was positive with a positivity 
threshold at 10-1 dilution. That of the MCV DNA from the suspected MCV's lesion was positive with a positivity threshold 
of up to 10 -6 dilution. No non-specific amplification was observed with the DNAs of the other pathogens responsible for 
lesions Cutaneous. The clinical diagnosis of the MCV was confirmed by PCR in 18 out of the 21 patients, ie 85.71%. On the 3 
patients with a negative MCV PCR, 2 were positive for the OPV PCR , reflecting the risk of confusion between clinical 
lesions due to Poxviruses. 
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Résumé                                                                                                                                                                                                           
Justification : Orthopoxvirus (OPV) et  Molluscum contagiosum virus (MCV) sont des Poxvirus impliqués dans les lésions 
cutanées d’origine virale chez l’homme. OPV infecte de nombreux vertébrés et le MCV infecte essentiellement l’Homme. La 
confusion est souvent observée entre les lésions cliniques  dues aux différents Poxvirus d’une part et d’autre part avec 
d’autres virus comme le virus de la varicelle. En Côte d’Ivoire, le diagnostic du MCV reste essentiellement clinique et celui 
des OPV est inexistant malgré le risque de circulation du virus. Cette étude vise à mettre au point la détection moléculaire 
des OPV et du MCV en Côte d’Ivoire. Matériel et méthode : ADN de Cowpoxvirus et 21 extraits d’ADN issus de lésions 
cutanées suspectes de MCV ont été analysés par PCR classique. Les amorces consensus (EACP1, EACP2)  issus du gène de 
l’hémagglutine de surface ont été utilisées pour la détection des OPV et  les amorces (MCV1, MCV2) ciblant le fragment K 
de l’ADN du MCV ont été utilisées. Une série dilution croissante de l’ADN du Cowpoxvirus et du MCV ont permis l’étude 
de la sensibilité de la méthode utilisée. Les ADN de  S aureus, de M.  ulcerans, du VZV, du HSV, du Virus de la rougeole et 
du virus de la varicelle ont été utilisés pour les tests de spécificités. Résultats : La détection de l’OPV à partir de la souche 
virale Cowpoxvirus était positive avec un seuil de positivité à la dilution 10-1. Celle du MCV à partir de l’ADN de lésion 
suspecte de MCV était positive avec un seuil de positivité pouvant aller jusqu’à la dilution 10 -6. Aucune amplification non 
spécifique n’a été observée avec les ADN des autres  pathogènes responsables de lésions cutanées. Le diagnostic clinique à 
MCV a été confirmé par la PCR chez 18 des 21  patients soit 85,71%. Sur les 3 patients à résultat PCR  MCV négatif, 2 étaient 
positifs pour la PCR OPV traduisant le risque de confusion entre les lésions cliniques dues aux Poxvirus. 





INTRODUCTION                                                                                                                                                                         
Poxviruses are double-stranded DNA with 
cytoplasmic multiplication. They have a number of 
autonomous elements allowing this 
intracytoplasmic multiplication unlike the majority 
of other viruses [1]. Several genes of this family of 
viruses including Orthopoxviruses (OPV) and 
Molluscum contgiosum virus (MCV) are involved in 
skin infections in humans and other vertebrates. 
Since the 1980s, the smallpox virus belonging to the 
Orthopox virus group has been eradicated [2]. 
However, viruses such as Monkeypox virus, 
Cowpox virus and other OPVs continue to infect 
humans accidentally but with a less severe degree of 
virulence than the smallpox virus [3]. Their 
eradication is problematic because they have many 
reservoirs. The emergence of Monkeypox virus, 
especially in Central Africa, with the 
epidemiological characteristics of the epidemic of 
1996 - 1997 in Zaire [3] and the appearance of the 
virus in 2003 in the USA makes it a global concern. 
Clinically, confusion has already been made 
between certain oxic infections and chickenpox 
according to the literature [5, 6]. Côte d'Ivoire is a 
probable zone of virus circulation [7, 8]. Despite this 
fact, diagnostic methods for OPVs in general and 
Monkeypox virus in particular are non-existent. 
The MCV is increasingly encountered with HIV 
infection. It is often involved in skin lesions in 
children. To date, in Côte d'Ivoire, the diagnosis of 
this virus remains essentially clinical whereas 
atypical clinical forms were encountered with HIV 
infection [9, 10]. 
In order to monitor the emergence of this group of 
viruses in the population in Côte d'Ivoire, it could 
be necessary to set up molecular diagnostic tools to 
detect a certain number of viruses of this family. 
MATERIALS AND METHODS: 
This is an experimental study of the analytical type 
carried out at the Pasteur Institute of Côte d'Ivoire 
on the site of Adiopodoumé to the platform of 
molecular biology in 2016. 
Biological material 
In this study, the following biological products were 
used: strains of Cowpox virus derived from 
Cowpox virus culture on a Vero cell supplied by the 
Pasteur Institute of Bangui for the technical 
development of the detection of the 
Orthopoxviruses. Cutaneous lesions of 21 patients 
suspected of MCV infection for the detection of the 
Molluscum contagiosum virus. Microorganisms 
involved in cutaneous infections in Côte d'Ivoire 
from various biological products of patients were 
used for primer specificity tests (Table 1). 
 
TABLE 1: PATHOGENS TESTED IN THE SPECIFICITY TEST OF PCR FOR THE ORTHOPOXVIRUS AND THE 
MOLLUSCUM C VIRUS 
Number Pathogens Sample type Laboratory where the 
pathogens  used were 
isolated 
Souche KN S. aureus Pus  UBY 
258UB Mycobacterium ulcerans Cutaneous lesion GER-Buruli 
017 HSV Herpex simplex virus Cerebrospinal fluid DVE 
014 VZV Virus de la varicelle Cerebrospinal fluid DVE 
258 G Virus de la rougeole Oropharyngeal secretion DVE 
DVE: Department of epidemic viruses of the Pasteur Institute of Côte d'Ivoire, GER-Buruli: Research group on Buruli ulcer 
of the Pasteur Institute of Côte d'Ivoire, UBY:  bacteriology unit of Hospital University Center of Yopougon 
METHODS                                                                                           
Pre-treatment of samples                                                                         
The cutaneous lesions were ground with mortar and 
dissolved in 2 ml of 1X PBS. They were then stored 
at -20 ° C until extraction of the DNA. 
DNA extraction                                                                          
The DNAs of the different microorganisms were 
extracted using the Nuclisens magnetic extraction 
protocol (Biomerieux). Briefly 400 µl samples were 
added to 800 µl of lysis buffer and incubated for 10 
min. Then 40 µl of magnetic silica was added to the 
mix and incubated for 10 minutes at laboratory 
temperature. The solution was centrifuged for 30 s 
at 13000 rpm. A series of washing was carried out 
on the silica-DNA complex using the Minimag 
(Biomerieux). An elution buffer was used after 
washing to collect 25 µl of DNA. 
Amplification and revelation                                                                         
A PCR using consensus primers of Orthopoxviruses 
designed from the virus surface membrane HA 
gene were used (Forward: EACP1: 5 'ATG ACA 
CGA TTG CCA ATA C 3', Reverse: EACP2: 5 'CTA 
GAC TTT GTT TTC TG 3 '; the desired PCR product 
band size being 942 bp[11]. Amplification 
conditions were as followingfor the detection of 
Orthopoxviruses:94 ° C 5 min (1 cycle), 94 ° C 30 sec, 
48 ° C 1 min, 72 ° C 1 Min) (36 cycles), 72 ° C 8 min 
(1 cycle). Concerning the Molluscum contagiosum 
virus, primers targeting the fragment K gene of the 
virus DNA were used (MCV Primer1: 
5’CCGATCTTTGCGAGCGTTCTTAA 3’ 'MCV 
Primer 2: 5'TCCCATACAGCGAGGACAGCATA 
3’), the desired PCR product being 167 bp size[12]. 




C sec, 65 ° C C 1 min, 72 ° C 1 min) (36 cycles), 72 ° 
C 8 min (1 cycle)  
The GoTaq G2 Flexi DNA polymerase kit (Promega 
Corporation, USA) was used for the PCR mixes 
containing 0.2µM of each primer, 1.5µM, MgCl, 
0.1µM dNTPs, 1 unit Taq polymerase, 1X of buffer 
and 5µl of DNA template for a final volume of 50µl. 
The revelation was made on a GelDoc Bioanalyzer 
(BioRad) after electrophoresis on 1.5% agarose gel. 
Study of sensitivity                                                                          
It was made from a dilution series from the DNA 
extracted of the Cowpoxvirus viral strain for 
Orthopoviruses and a positive DNA MCV sample. 
Study of the specificity                                                               
It was realized by carrying out PCR from the 
primers specific to OPV (EACP1, EACP2) and MCV 
(MCV1, MCV2) in the presence of DNA from 
different microorganisms mentioned in Table 1. 
RESULTS                                                                                      
The PCR carried out using our positive Cowpox 
virus DNA control allowed us to validate our 
method of amplification. Indeed, two samples 
corresponding to the pure sample and the dilutions 
10-1 of our controls were positive (FIG. 1). The 
dilution series of 10-2 to 10-5 of the Cowpox virus 
DNA control obtained from 200 µl of viral strain on 
Véro cell being negative by PCR thus fixing the 
detection threshold of our method at 10-1 for a 
volume of 200 µl.of viral strain. No amplification 
was detected with the DNAs  from other pathogens 
frequently involved in cutaneous infections in Côte 







This sensitivity could improve by performing 
extraction with a larger volume of viral strain. 
The MCV detection tests were performed using 
cutaneous lesions from 21 patients diagnosed with 
MCV infection clinically. The patients had the 
epidemiological and clinical characteristics 
presented in Table 2. 
 
FIG 1 :DILUTION SERIES OF COXPOXVIRUS 
DNA  
(P = undiluted Cowpoxvirus DNA, P-1 to P-5 = 
dilution series 
CN: Negative control M: Marker (1500 bp to 100 
bp) 
FIG 2 : SPECIFICITY TEST RESULT 
CP = Cowpoxvirus (942 bp), 01 = MCV, 02 = 845 G (Measles virus, 
03 = 258ub (M ulcerans), 04 = S aureus, 05 = 014 VZV (varicella 






TABLE 2: CHARACTERISTICS OF THE 21 PATIENTS WHOSE SAMPLES WERE TESTED FOR THE DETECTION OF 
MCV 
Number Age  Sex Clinical Lésion  
1 /YOP 15 Months M PAPULES 
2/YOP 8 Years M PAPULES 
5/YOP 24 Years F PAPULES 
6/YOP 7 Years F VESICLES 
7/YOP 4 Years M CRUSTS 
8/YOP 3 Years M VESICLES 
9/YOP 5 Years F MACULES 
10/YOP 4 Years F PUSTULES 
11/YOP 3 Years M MACULES 
12/YOP 13 Years M VESICLES 
13/YOP 7 Years F MACULES 
14/YOP 5 Years F MACULES 
2306 6 Years F VESICLES 
2503 4 Years F PAPULES 
2602 4 Years F VESICLES 
2648 6 Years F PAPULES 
2649 9 Years M PAPULES 
2650 6 Years F PAPULES 
2647 3 Years F PAPULES 
2761 2 Years F Unspecified 
2762 28 Years F Unspecified 
 
A test for detection of MCV was carried out with the 
first three samples (1 / YOP, 2 / YOP, 5 / YOP). 
Each sample was diluted to 10-1 to reduce the risk of 
PCR inhibition (Figure 3). The 167 bp PCR product 
was revealed for all three samples corresponding to 
positive MCV detection results. 
 
 
FIGURE 3: MCV PCR TEST OF SAMPLES  




A dilution series of 10-1 to 10-9 was carried out with 
the 1 / YOP sample in order to determine the 
sensitivity threshold of the PCR. Positive bands 
were observed up to 10-6 dilution (Figure 4). The 
specificity tests carried out with the DNA of other 
pathogens did not reveal nonspecific amplifications 
due to microorganisms often involved in human 
skin lesions. Of the 21 suspected samples of MCV 
infection, 18 were confirmed on the 21, ie 85.71% 
agreement between the clinic and the molecular test 
used. Samples 2503, 2306 and 010/YOP were 
negative (Figure 5). Of the three negative samples, 
two were found to be positive for the conventional 









DISCUSSION                                                                          
Molecular tools are increasingly being developed 
for the diagnosis of Poxviruses [13, 14, 15]. They have 
the advantage, on the one hand, of making a rapid 
and precise diagnosis and of others by avoiding the 
constraints of biosafety and biosurety related to the 
cultivation of Poxviruses; this development of the 
molecular detection for Poxviruses in our laboratory 
falls within this framework. It is one of the first 
studies in the establishment of the molecular 
diagnosis of Poxviruses in human medicine in Côte 
d'Ivoire. Despite the fact that this study may present 
biases related to the absence of a reference strain of  
 
Poxvirus whose acquisition remains subject to 
rigorous measures in this context of global 
bioterrorism, this study constitutes a starting point 
in the implementation of the development of 
molecular tools for the detection of Poxviruses in 
Côte d'Ivoire. A discrepancy between the clinical 
diagnosis of MCV infection and the molecular 
outcome in three patients was observed in this 
study. Thus, two of the patients presented with 
OPV lesions. This clinical confusion is related to the 
similarity between the clinical lesions due to the 
different genera of the Chordopoxviridae subfamily. 
Thus, co-circulations have also been reported [16, 
FIG 4: MCV DNA DILUTION SERIES  




 = dilution series, CN: Negative Control M: Marker (1500 bp to 100 bp 
FIG 5 : RESULTS OF PATIENTS SUSPECTED OF MCV INFECTIONS 





17, 18], hence the need for a biological diagnosis 
despite the strong clinical suspicion. 
CONCLUSION                                                                        
The emergence of Monkeypox virus in Central 
Africa is a signal for West Africa. It is necessary to 
set up rapid diagnostic methods. This study is part 
of this approach. However, its sensitivity needs to 
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